易明医药 (002826)
TIBET AIM PHARM. INC.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 19067.78
- Circulating A-Shares(W): 17432.64
- Earnings Per Share(RMB): 0.4400
- Net Assets Per Share(RMB): 4.2068
- Operating Revenue(W RMB): 48898.40
- Total Profit(W RMB): 10221.83
- Net Profit Attributable to Parent(W RMB): 8176.33
- Net Profit Growth Rate(%): 95.52
- Weighted Return on Equity(%): 10.5400
- Operating Cash Flow Per Share(RMB): 0.7850
- Undistributed Profit Per Share(RMB): 2.0966
- Capital Reserve Per Share(RMB): 1.2034
2. Main Business
The main business covers:
- Self-produced pharmaceutical business
- Third-party cooperative pharmaceutical business
- Active Pharmaceutical Ingredient (API) business
- Pharmaceutical raw material sales business
- Pharmaceutical promotion service business
3. Company Basic Information
- Company Name: Tibet Aim Pharm. Inc.
- Listing Date: 2016-12-09
- Industry: Pharmaceutical Manufacturing
- Address: 37F, Building B, Liangjiang International, Tianfu 1st Street, Chengdu, Sichuan Province, China
- Website: www.emyy.cn
- Company Profile: The company's predecessor, Yiming Co., Ltd., was established on December 29, 2007. In December 2014, Yiming Co., Ltd. was restructured into Yiming Pharmaceutical Co., Ltd. based on the audited net assets of RMB 151,184,748.97 as of June 30, 2014, with a conversion ratio of 1:0.8929, resulting in a total share capital of 135,000,000 shares. All assets, liabilities, business, and personnel of Yiming Co., Ltd. were succeeded by the restructured joint-stock company. On December 31, 2014, the company completed the industrial and commercial change registration procedures at the Lhasa Economic and Technological Development Zone Administration for Industry and Commerce and obtained the "Business License of Enterprise Legal Person" with registration number 540000800000113.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Beijing Fuhao Enterprise Management Partnership (Limited Partnership) | General Legal Person | 4385.59 | 25.16 |
| 2 | Zhongzheng Qianyuan Capital Management Co., Ltd. - Zhongzheng Qianyuan No. 3 Private Securities Investment Fund | Private Securities Investment Fund | 168.00 | 0.96 |
| 3 | Shenzhen Qianhai Houbo Capital Management Co., Ltd. - Houbo Lingwang No. 2 New Opportunity Private Securities Investment Fund | Private Securities Investment Fund | 132.36 | 0.76 |
| 4 | Hongshen Investment Holding Group (Hainan) Co., Ltd. | General Legal Person | 130.09 | 0.75 |
| 5 | Wanjia CSI 2000 Index Enhanced Securities Investment Fund Class A | Fund | 0.90 | 0.01 |
5. Concept Sectors
- Generic Drugs
- Control Change
- Micro-Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
